Idexx Laboratories | IDXX - Sales Revenues

Stock Price
647.67
Daily Change
4.08 0.63%
Monthly
-9.36%
Yearly
40.87%
Q1 Forecast
649.81

Idexx Laboratories reported $1.09B in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Abbott USD 11.46B 90M Dec/2025
Align Technology USD 1.05B 54.3M Dec/2025
Dentsply International USD 904M 32M Sep/2025
Dexcom USD 1.21B 50M Sep/2025
Edwards Lifesciences USD 1.55B 20M Sep/2025
Fujifilm JPY 857.35B 34.47B Dec/2025
Globus Medical USD 769M 23.7M Sep/2025
Henry Schein USD 3.34B 100M Sep/2025
Hologic USD 1.05B 0 Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Insulet USD 706.3M 57.2M Sep/2025
Integra LifeSciences USD 402.06M 13.54M Sep/2025
Intuitive Surgical USD 2.87B 360M Dec/2025
Masimo USD 371.5M 600K Sep/2025
Neogen USD 224.69M 15.5M Sep/2025
ResMed USD 1.4B 100M Dec/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Steris USD 1.5B 470M Dec/2025
Tandem Diabetes Care USD 249.25M 8.57M Sep/2025
Teleflex USD 913M 132.11M Sep/2025
Thermo Fisher Scientific USD 12.21B 1.09B Dec/2025
Zoetis USD 2.4B 60M Sep/2025